Report cover image

NGS Based RNA Sequencing Market

Publisher Global Insight Services
Published Oct 16, 2025
Length 389 Pages
SKU # GIS20476397

Description

NGS Based RNA Sequencing Market is anticipated to expand from $3.31 billion in 2024 to $14.47 billion by 2034, growing at a CAGR of approximately 15.9%. The NGS-Based RNA-Sequencing Market encompasses the industry centered around next-generation sequencing technologies applied to RNA analysis. This market includes platforms, reagents, and services that enable comprehensive transcriptome profiling, gene expression analysis, and novel RNA discovery. It serves sectors such as healthcare, pharmaceuticals, and biotechnology, facilitating advancements in personalized medicine, disease research, and therapeutic development.

Segment Overview

The NGS-Based RNA-Sequencing Market is experiencing robust growth, driven by advancements in genomic research and personalized medicine. Among the segments, the consumables sub-segment emerges as the top performer, attributed to the recurring demand for reagents and kits essential for sequencing processes. Sequencing platforms follow as the second-highest performing sub-segment, benefiting from technological innovations and decreasing costs. Regionally, North America leads the market, propelled by substantial investments in healthcare infrastructure and research initiatives. Europe stands as the second most lucrative region, supported by favorable government policies and a strong focus on biotechnology advancements. Within these regions, the United States and Germany are the key contributors, respectively, due to their robust research ecosystems and collaborations between academia and industry. These insights underscore the market's dynamic nature, highlighting opportunities for stakeholders to capitalize on technological advancements and strategic regional positioning.

Global tariffs and geopolitical risks are significantly influencing the NGS-Based RNA-Sequencing Market. In Europe, strategies are pivoting towards self-reliance in biotechnology, driven by trade tensions and the need for robust healthcare infrastructures. Asia, particularly China and India, is witnessing accelerated investments in domestic sequencing technologies, propelled by export restrictions and a desire for technological sovereignty. Germany and Japan are enhancing collaborations to mitigate supply chain vulnerabilities, focusing on innovation and research partnerships. South Korea and Taiwan are navigating these challenges by bolstering their semiconductor capacities, crucial for sequencing equipment. The parent market is experiencing robust growth globally, with an increasing demand for personalized medicine and genomic research. By 2035, the market is expected to flourish, contingent upon geopolitical stability and diversified supply chains. Middle East conflicts, impacting global energy prices, add another layer of complexity, influencing operational costs and timelines across the biotechnology sector.

Key Trends and Drivers

The NGS-Based RNA-Sequencing Market is experiencing dynamic growth, propelled by several pivotal trends and drivers. Foremost among these is the increasing demand for personalized medicine, which necessitates advanced genomic analysis to tailor treatments to individual genetic profiles. This trend is further augmented by the declining cost of sequencing technologies, making RNA sequencing more accessible and affordable for research and clinical applications.

Moreover, the rise in cancer research initiatives is significantly driving the market, as RNA sequencing offers unparalleled insights into tumor biology and the identification of novel biomarkers. The expanding application of RNA sequencing in agricultural biotechnology also presents lucrative opportunities, as it aids in understanding plant genetics for improved crop yields and resilience.

Furthermore, government funding and support for genomic research are fostering innovation and development in this sector. The integration of artificial intelligence and machine learning for data analysis in RNA sequencing is emerging as a critical trend, enhancing the accuracy and speed of genomic interpretations. This technological synergy is set to unlock new possibilities in the market, paving the way for groundbreaking discoveries and applications.

Key Players

Illumina, Oxford Nanopore Technologies, Pacific Biosciences, BGI Genomics, Qiagen, Thermo Fisher Scientific, Roche Sequencing Solutions, Agilent Technologies, Perkin Elmer, 10x Genomics, Bio- Rad Laboratories, Genewiz, Takara Bio, GATC Biotech, Eurofins Genomics, Macrogen, Novogene, Zymo Research, Lexogen, Singular GenomicsResearch Scope
  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.
Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

Please Note: This report will be delivered by publisher within 2-3 business days of order confirmation.

Table of Contents

389 Pages
NGS-Based RNA-Sequencing Market Overview
Chapter 1
Sections: 1.1 Objectives of the Study
1.2 NGS-Based RNA-Sequencing Market Definition and Scope of the Report
1.3 Report Limitations
1.4 Years & Currency Considered in the Study
1.5 Research Methodologies
1.5.1 Secondary Research
1.5.2 Primary Research
1.5.3 Market Size Estimation: Top-Down Approach
1.5.4 Market Size Estimation: Bottom-Up Approach
1.5.5 Data Triangulation and Validation
Executive Summary
Chapter 2
Sections: 2.1 Summary
2.2 Key Opinion Leaders
2.3 Key Highlights of the Market, by Type
2.4 Key Highlights of the Market, by Product
2.5 Key Highlights of the Market, by Services
2.6 Key Highlights of the Market, by Technology
2.7 Key Highlights of the Market, by Application
2.8 Key Highlights of the Market, by End User
2.9 Key Highlights of the Market, by Component
2.10 Key Highlights of the Market, by Functionality
2.11 Key Highlights of the Market, by Deployment
2.12 Key Highlights of the Market, by Stage
2.13 Key Highlights of the Market, by North America
2.14 Key Highlights of the Market, by Europe
2.15 Key Highlights of the Market, by Asia-Pacific
2.16 Key Highlights of the Market, by Latin America
2.17 Key Highlights of the Market, by Middle East
2.18 Key Highlights of the Market, by Africa
Premium Insights on the Market
Chapter 3
Sections: 3.1 Market Attractiveness Analysis, by Region
3.2 Market Attractiveness Analysis, by Type
3.3 Market Attractiveness Analysis, by Product
3.4 Market Attractiveness Analysis, by Services
3.5 Market Attractiveness Analysis, by Technology
3.6 Market Attractiveness Analysis, by Application
3.7 Market Attractiveness Analysis, by End User
3.8 Market Attractiveness Analysis, by Component
3.9 Market Attractiveness Analysis, by Functionality
3.10 Market Attractiveness Analysis, by Deployment
3.11 Market Attractiveness Analysis, by Stage
3.12 Market Attractiveness Analysis, by North America
3.13 Market Attractiveness Analysis, by Europe
3.14 Market Attractiveness Analysis, by Asia-Pacific
3.15 Market Attractiveness Analysis, by Latin America
3.16 Market Attractiveness Analysis, by Middle East
3.17 Market Attractiveness Analysis, by Africa
NGS-Based RNA-Sequencing Market Outlook
Chapter 4
Sections: 4.1 NGS-Based RNA-Sequencing Market Segmentation
4.2 Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Trends
4.2.3 Market Restraints
4.2.4 Market Opportunities
4.3 Porters Five Forces Analysis
4.3.1 Threat of New Entrants
4.3.2 Threat of Substitutes
4.3.3 Bargaining Power of Buyers
4.3.4 Bargaining Power of Supplier
4.3.5 Competitive Rivalry
4.4 PESTLE Analysis
4.5 Value Chain Analysis
4.6 4Ps Model
4.7 ANSOFF Matrix
NGS-Based RNA-Sequencing Market Strategy
Chapter 5
Sections: 5.1 Parent Market Analysis
5.2 Supply-Demand Analysis
5.3 Consumer Buying Interest
5.4 Case Study Analysis
5.5 Pricing Analysis
5.6 Regulatory Landscape
5.7 Supply Chain Analysis
5.8 Competition Product Analysis
5.9 Recent Developments
NGS-Based RNA-Sequencing Market Size
Chapter 6
Sections: 6.1 NGS-Based RNA-Sequencing Market Size, by Value
6.2 NGS-Based RNA-Sequencing Market Size, by Volume
NGS-Based RNA-Sequencing Market, by Type
Chapter 7
Sections: 7.1 Market Overview
7.2 Whole Transcriptome Sequencing
7.2.1 Key Market Trends & Opportunity Analysis
7.2.2 Market Size and Forecast, by Region
7.3 Targeted RNA Sequencing
7.3.1 Key Market Trends & Opportunity Analysis
7.3.2 Market Size and Forecast, by Region
7.4 Small RNA Sequencing
7.4.1 Key Market Trends & Opportunity Analysis
7.4.2 Market Size and Forecast, by Region
7.5 Single-cell RNA Sequencing
7.5.1 Key Market Trends & Opportunity Analysis
7.5.2 Market Size and Forecast, by Region
7.6 Others
7.6.1 Key Market Trends & Opportunity Analysis
7.6.2 Market Size and Forecast, by Region
NGS-Based RNA-Sequencing Market, by Product
Chapter 8
Sections: 8.1 Market Overview
8.2 Sequencing Platforms
8.2.1 Key Market Trends & Opportunity Analysis
8.2.2 Market Size and Forecast, by Region
8.3 Kits and Reagents
8.3.1 Key Market Trends & Opportunity Analysis
8.3.2 Market Size and Forecast, by Region
8.4 Software
8.4.1 Key Market Trends & Opportunity Analysis
8.4.2 Market Size and Forecast, by Region
8.5 Others
8.5.1 Key Market Trends & Opportunity Analysis
8.5.2 Market Size and Forecast, by Region
NGS-Based RNA-Sequencing Market, by Services
Chapter 9
Sections: 9.1 Market Overview
9.2 Data Analysis
9.2.1 Key Market Trends & Opportunity Analysis
9.2.2 Market Size and Forecast, by Region
9.3 Sequencing Services
9.3.1 Key Market Trends & Opportunity Analysis
9.3.2 Market Size and Forecast, by Region
9.4 Others
9.4.1 Key Market Trends & Opportunity Analysis
9.4.2 Market Size and Forecast, by Region
NGS-Based RNA-Sequencing Market, by Technology
Chapter 10
Sections: 10.1 Market Overview
10.2 Sequencing by Synthesis
10.2.1 Key Market Trends & Opportunity Analysis
10.2.2 Market Size and Forecast, by Region
10.3 Ion Semiconductor Sequencing
10.3.1 Key Market Trends & Opportunity Analysis
10.3.2 Market Size and Forecast, by Region
10.4 Single-molecule Real-time Sequencing
10.4.1 Key Market Trends & Opportunity Analysis
10.4.2 Market Size and Forecast, by Region
10.5 Nanopore Sequencing
10.5.1 Key Market Trends & Opportunity Analysis
10.5.2 Market Size and Forecast, by Region
10.6 Others
10.6.1 Key Market Trends & Opportunity Analysis
10.6.2 Market Size and Forecast, by Region
NGS-Based RNA-Sequencing Market, by Application
Chapter 11
Sections: 11.1 Market Overview
11.2 Clinical Diagnostics
11.2.1 Key Market Trends & Opportunity Analysis
11.2.2 Market Size and Forecast, by Region
11.3 Drug Discovery and Development
11.3.1 Key Market Trends & Opportunity Analysis
11.3.2 Market Size and Forecast, by Region
11.4 Agricultural Genomics
11.4.1 Key Market Trends & Opportunity Analysis
11.4.2 Market Size and Forecast, by Region
11.5 Biomarker Discovery
11.5.1 Key Market Trends & Opportunity Analysis
11.5.2 Market Size and Forecast, by Region
11.6 Others
11.6.1 Key Market Trends & Opportunity Analysis
11.6.2 Market Size and Forecast, by Region
NGS-Based RNA-Sequencing Market, by End User
Chapter 12
Sections: 12.1 Market Overview
12.2 Academic Research Institutions
12.2.1 Key Market Trends & Opportunity Analysis
12.2.2 Market Size and Forecast, by Region
12.3 Pharmaceutical and Biotechnology Companies
12.3.1 Key Market Trends & Opportunity Analysis
12.3.2 Market Size and Forecast, by Region
12.4 Hospitals and Clinics
12.4.1 Key Market Trends & Opportunity Analysis
12.4.2 Market Size and Forecast, by Region
12.5 Contract Research Organizations
12.5.1 Key Market Trends & Opportunity Analysis
12.5.2 Market Size and Forecast, by Region
12.6 Others
12.6.1 Key Market Trends & Opportunity Analysis
12.6.2 Market Size and Forecast, by Region
NGS-Based RNA-Sequencing Market, by Component
Chapter 13
Sections: 13.1 Market Overview
13.2 Hardware
13.2.1 Key Market Trends & Opportunity Analysis
13.2.2 Market Size and Forecast, by Region
13.3 Software
13.3.1 Key Market Trends & Opportunity Analysis
13.3.2 Market Size and Forecast, by Region
13.4 Services
13.4.1 Key Market Trends & Opportunity Analysis
13.4.2 Market Size and Forecast, by Region
13.5 Others
13.5.1 Key Market Trends & Opportunity Analysis
13.5.2 Market Size and Forecast, by Region
NGS-Based RNA-Sequencing Market, by Functionality
Chapter 14
Sections: 14.1 Market Overview
14.2 Gene Expression Profiling
14.2.1 Key Market Trends & Opportunity Analysis
14.2.2 Market Size and Forecast, by Region
14.3 De Novo Transcriptome Assembly
14.3.1 Key Market Trends & Opportunity Analysis
14.3.2 Market Size and Forecast, by Region
14.4 Epigenetics
14.4.1 Key Market Trends & Opportunity Analysis
14.4.2 Market Size and Forecast, by Region
14.5 Others
14.5.1 Key Market Trends & Opportunity Analysis
14.5.2 Market Size and Forecast, by Region
NGS-Based RNA-Sequencing Market, by Deployment
Chapter 15
Sections: 15.1 Market Overview
15.2 On-premise
15.2.1 Key Market Trends & Opportunity Analysis
15.2.2 Market Size and Forecast, by Region
15.3 Cloud-based
15.3.1 Key Market Trends & Opportunity Analysis
15.3.2 Market Size and Forecast, by Region
15.4 Others
15.4.1 Key Market Trends & Opportunity Analysis
15.4.2 Market Size and Forecast, by Region
NGS-Based RNA-Sequencing Market, by Stage
Chapter 16
Sections: 16.1 Market Overview
16.2 Research
16.2.1 Key Market Trends & Opportunity Analysis
16.2.2 Market Size and Forecast, by Region
16.3 Clinical
16.3.1 Key Market Trends & Opportunity Analysis
16.3.2 Market Size and Forecast, by Region
16.4 Others
16.4.1 Key Market Trends & Opportunity Analysis
16.4.2 Market Size and Forecast, by Region

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us